FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy

DEALS: Qiagen buys key assets

Tools


Qiagen buys key assets


DEALS

WHO

WITH

WHAT

SCOOP

Altana

Eckhart

$768 million buyout

Once the deal is complete, Altana will add Eckhart's chemicals and pigments unit to its chemicals division and spin the venture off as a separate company.

Qiagen

SuNyx

asset buyout

Qiagen buys technology that examines sample preparation by leveraging unique, nanotechnology-based surface structures.

Qiagen

LumiCyte

asset buyout

LumiCyte has been developing capability that dramatically increases the limits of detection achievable through mass spectroscopy.


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceBiotech Email Newsletter:

More stories about Biotech Venture Capital   Qiagen   assets   altana   nanotechnology